PTD-DBM alternatives.

6 compounds compared to PTD-DBM, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

PTD-DBM is a laboratory tool rather than a product. It fuses a cell-penetrating domain to a peptide mimicking the Dishevelled-binding region of CXXC5, letting it act as a competitive decoy in Wnt and beta-catenin signaling, and it was built to study skin and hair-follicle biology. People find it through hair-growth discussion and then look for an alternative when they learn what it is: not approved by the FDA or any major regulator, not present in marketed dermatologic products, and supported only by preclinical work with no registered human clinical program for the peptide itself. No peptide in this signaling pathway has human evidence to move toward.

What you're comparing against
PTD-DBM
F tier · 12/100Research / preclinical

PTD-DBM is a synthetic, cell-permeable peptide whose name stands for "Protein Transduction Domain–Dishevelled Binding Motif." It fuses a short protein-transduction (cell-penetrating) domain to a peptide sequence that mimics the Dishevelled-binding region of the protein CXXC5, allowing it to act as a competitive decoy.

Ranked by evidence · strongest first
  1. 01
    Afamelanotide
    A tierFDA-approved
    Melanotan I · Scenesse

    Same category: skin & cosmetic. FDA-approved.

  2. 02
    GHK-Cu
    D tierCosmetic / topical
    copper peptide

    Same category: skin & cosmetic. Cosmetic / topical.

  3. 03
    Argireline
    D tierCosmetic / topical
    acetyl hexapeptide-8

    Same category: skin & cosmetic. Cosmetic / topical.

  4. 04
    Melanotan II
    D tierResearch / preclinical

    Same category: skin & cosmetic. Research / preclinical.

  5. 05
    Matrixyl
    D tierCosmetic / topical
    palmitoyl pentapeptide

    Same category: skin & cosmetic. Cosmetic / topical.

  6. 06
    SNAP-8
    D tierCosmetic / topical
    acetyl octapeptide-3

    Same category: skin & cosmetic. Cosmetic / topical.

How this list is built

An “alternative” here means a compound that shares PTD-DBM's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds